Filing Details
- Accession Number:
- 0001140361-10-015451
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-06 13:00:00
- Reporting Period:
- 2010-04-05
- Filing Date:
- 2010-04-06
- Accepted Time:
- 2010-04-06 14:34:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184149 | W Jonathan Ayers | One Idexx Drive Westbrook ME 04092 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-04-05 | 20,000 | $12.60 | 168,149 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-04-05 | 50,000 | $12.60 | 218,149 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-04-05 | 40,725 | $57.96 | 177,424 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-04-05 | 20,000 | $0.00 | 20,000 | $12.60 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-04-05 | 50,000 | $0.00 | 50,000 | $12.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 740,320 | 2012-01-28 | No | 4 | M | Direct | |
| 690,320 | 2012-01-28 | No | 4 | M | Direct |
Footnotes
- Includes 115 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 3/31/2010.
- The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/3/2009.
- The sale price reported above reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged between $57.63 and $58.16. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.
- Grant of option to buy shares of common stock exercisable in five equal annual increments beginning on the first anniversary date (1/28/2003) of the grant.
Billionaire Hedge Funds
